Dynamic Technology Lab Private Ltd purchased a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,572 shares of the company’s stock, valued at approximately $219,000.

Other institutional investors also recently added to or reduced their stakes in the company. US Bancorp DE raised its holdings in Nu Skin Enterprises by 3.3% in the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after acquiring an additional 65 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Nu Skin Enterprises during the third quarter worth approximately $148,000. Texas Yale Capital Corp. bought a new position in shares of Nu Skin Enterprises during the second quarter worth approximately $217,000. Shelton Capital Management bought a new position in shares of Nu Skin Enterprises during the second quarter worth approximately $232,000. Finally, Quantbot Technologies LP bought a new position in shares of Nu Skin Enterprises during the third quarter worth approximately $229,000. 77.54% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) traded down $0.82 on Friday, hitting $65.56. 511,700 shares of the stock traded hands, compared to its average volume of 661,326. Nu Skin Enterprises, Inc. has a 12 month low of $46.76 and a 12 month high of $68.50. The company has a market capitalization of $3,450.00, a PE ratio of 23.46, a PEG ratio of 2.41 and a beta of 1.57. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.76. The business had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The firm’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter last year, the business posted $0.98 EPS. sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 3.23 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Investors of record on Friday, November 17th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, November 16th. This represents a $1.44 annualized dividend and a dividend yield of 2.20%. Nu Skin Enterprises’s dividend payout ratio is 52.75%.

NUS has been the topic of several recent research reports. Zacks Investment Research cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $62.00.

In related news, President Ryan S. Napierski sold 11,667 shares of the stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total transaction of $744,821.28. Following the sale, the president now owns 71,634 shares in the company, valued at approximately $4,573,114.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Joseph Y. Chang sold 13,497 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $62.06, for a total transaction of $837,623.82. Following the sale, the insider now owns 66,563 shares in the company, valued at approximately $4,130,899.78. The disclosure for this sale can be found here. Insiders have sold a total of 68,600 shares of company stock worth $4,298,104 in the last quarter. 5.20% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: This article was first posted by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/dynamic-technology-lab-private-ltd-takes-219000-position-in-nu-skin-enterprises-inc-nus/1751748.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.